• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动脉粥样硬化中平滑肌泡沫细胞形成的途径。

Pathways of smooth muscle foam cell formation in atherosclerosis.

机构信息

Department of Medicine, Centre for Heart Lung Innovation, Providence Healthcare Research Institute at St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.

出版信息

Curr Opin Lipidol. 2019 Apr;30(2):117-124. doi: 10.1097/MOL.0000000000000574.

DOI:10.1097/MOL.0000000000000574
PMID:30664015
Abstract

PURPOSE OF REVIEW

Smooth muscle cells (SMCs) are the major cell type in human atherosclerosis-prone arteries and take up excess lipids, thereby contributing to luminal occlusion. Here we provide a focused review on pathways by which smooth muscle cells (SMCs) can become foam cells in atherosclerosis.

RECENT FINDINGS

A synthesis of recent and older investigations provides key mechanistic insights into SMC foam cell formation. LDL and other apoB-containing lipoproteins are modified by a diverse array of oxidative, enzymatic, and nonenzymatic processes present in the arterial intima. These modifications of LDL all promote the aggregation of LDL (agLDL), a key finding from analysis of arterial lesion particles. Scavenger receptor and phagocytic capacity of SMCs can vary greatly, perhaps related to differences in SMC phenotype or in-vitro cell culture environments, and can be increased with exposure to cytokines, growth factors, and cholesterol. Macrophages promote the formation of SMC foam cells in direct or indirect co-culture models.

SUMMARY

SMCs contribute significantly to the foam cell population in atherosclerosis. Further investigation and identification of key mechanisms of SMC foam cell formation will help drive new therapeutics to reduce cardiovascular disease.

摘要

目的综述

平滑肌细胞(SMC)是人类易患动脉粥样硬化动脉中的主要细胞类型,它们摄取过多的脂质,从而导致管腔闭塞。本文重点综述了平滑肌细胞(SMC)成为动脉粥样硬化泡沫细胞的途径。

最近的发现

对近期和早期研究的综合分析为 SMC 泡沫细胞形成的机制提供了关键的见解。LDL 和其他载脂蛋白 B 含脂蛋白通过存在于动脉内膜中的多种氧化、酶和非酶过程而被修饰。这些 LDL 的修饰都促进 LDL 的聚集(agLDL),这是对动脉病变颗粒分析的一个关键发现。SMC 的清道夫受体和吞噬能力可能有很大差异,这可能与 SMC 表型或体外细胞培养环境的差异有关,并可以通过暴露于细胞因子、生长因子和胆固醇来增加。巨噬细胞在直接或间接共培养模型中促进 SMC 泡沫细胞的形成。

总结

SMC 对动脉粥样硬化中的泡沫细胞群体有很大的贡献。进一步研究和确定 SMC 泡沫细胞形成的关键机制将有助于推动新的治疗方法来减少心血管疾病。

相似文献

1
Pathways of smooth muscle foam cell formation in atherosclerosis.动脉粥样硬化中平滑肌泡沫细胞形成的途径。
Curr Opin Lipidol. 2019 Apr;30(2):117-124. doi: 10.1097/MOL.0000000000000574.
2
Smooth muscle cell phenotypic switch: implications for foam cell formation.平滑肌细胞表型转换:对泡沫细胞形成的影响。
Curr Opin Lipidol. 2014 Oct;25(5):374-9. doi: 10.1097/MOL.0000000000000113.
3
Enzymatically Modified Low-Density Lipoprotein Promotes Foam Cell Formation in Smooth Muscle Cells via Macropinocytosis and Enhances Receptor-Mediated Uptake of Oxidized Low-Density Lipoprotein.酶修饰的低密度脂蛋白通过巨吞饮作用促进平滑肌细胞中泡沫细胞的形成,并增强受体介导的氧化型低密度脂蛋白的摄取。
Arterioscler Thromb Vasc Biol. 2016 Jun;36(6):1101-13. doi: 10.1161/ATVBAHA.116.307306. Epub 2016 Apr 14.
4
So Much Cholesterol: the unrecognized importance of smooth muscle cells in atherosclerotic foam cell formation.如此多的胆固醇:平滑肌细胞在动脉粥样硬化泡沫细胞形成中未被认识到的重要性。
Curr Opin Lipidol. 2016 Apr;27(2):155-61. doi: 10.1097/MOL.0000000000000279.
5
Contribution of monocyte-derived macrophages and smooth muscle cells to arterial foam cell formation.单核细胞衍生的巨噬细胞和平滑肌细胞对动脉泡沫细胞形成的贡献。
Cardiovasc Res. 2012 Jul 15;95(2):165-72. doi: 10.1093/cvr/cvs094. Epub 2012 Feb 15.
6
A novel in vitro model for the study of plaque development in atherosclerosis.一种用于研究动脉粥样硬化斑块形成的新型体外模型。
Thromb Haemost. 2006 Jan;95(1):182-9.
7
NG2 Proteoglycan Ablation Reduces Foam Cell Formation and Atherogenesis via Decreased Low-Density Lipoprotein Retention by Synthetic Smooth Muscle Cells.NG2蛋白聚糖缺失通过减少合成型平滑肌细胞对低密度脂蛋白的潴留来降低泡沫细胞形成和动脉粥样硬化发生。
Arterioscler Thromb Vasc Biol. 2016 Jan;36(1):49-59. doi: 10.1161/ATVBAHA.115.306074. Epub 2015 Nov 5.
8
Cholesterol homeostasis and high-density lipoprotein formation in arterial smooth muscle cells.动脉平滑肌细胞中的胆固醇稳态和高密度脂蛋白形成。
Trends Cardiovasc Med. 2010 Apr;20(3):96-102. doi: 10.1016/j.tcm.2010.09.002.
9
ATP-binding cassette transporter A1 expression and apolipoprotein A-I binding are impaired in intima-type arterial smooth muscle cells.内膜型动脉平滑肌细胞中ATP结合盒转运蛋白A1的表达及载脂蛋白A-I结合功能受损。
Circulation. 2009 Jun 30;119(25):3223-31. doi: 10.1161/CIRCULATIONAHA.108.841130. Epub 2009 Jun 15.
10
Smooth muscle cell fate and plasticity in atherosclerosis.动脉粥样硬化中的平滑肌细胞命运和可塑性。
Cardiovasc Res. 2018 Mar 15;114(4):540-550. doi: 10.1093/cvr/cvy022.

引用本文的文献

1
Circ_HUWE1: a novel regulator of lipid accumulation, inflammation, and gut microbiota in atherosclerosis.环状RNA-HUWE1:动脉粥样硬化中脂质积累、炎症和肠道微生物群的新型调节因子
Cell Biosci. 2025 Jul 19;15(1):105. doi: 10.1186/s13578-025-01440-8.
2
Vascular Smooth Muscle Cells: A Therapeutic Target in Atherosclerosis.血管平滑肌细胞:动脉粥样硬化的治疗靶点
Rev Cardiovasc Med. 2025 Jun 26;26(6):28240. doi: 10.31083/RCM28240. eCollection 2025 Jun.
3
Protective effect of Salvianolic acid B against atherosclerosis: a preclinical systematic review and meta-analysis.
丹酚酸B对动脉粥样硬化的保护作用:一项临床前系统评价与荟萃分析
Front Pharmacol. 2025 Jun 18;16:1548811. doi: 10.3389/fphar.2025.1548811. eCollection 2025.
4
Exosomes derived from baicalin‑pretreated mesenchymal stem cells mitigate atherosclerosis by regulating the SIRT1/NF‑κB signaling pathway.黄芩苷预处理间充质干细胞来源的外泌体通过调节SIRT1/NF-κB信号通路减轻动脉粥样硬化。
Mol Med Rep. 2025 May;31(5). doi: 10.3892/mmr.2025.13491. Epub 2025 Mar 14.
5
The oral microbiota: new insight into intracranial aneurysms.口腔微生物群:对颅内动脉瘤的新见解。
Ann Med. 2025 Dec;57(1):2451191. doi: 10.1080/07853890.2025.2451191. Epub 2025 Jan 13.
6
Mechanistic insights into the regression of atherosclerotic plaques.动脉粥样硬化斑块消退的机制性见解。
Front Physiol. 2024 Nov 19;15:1473709. doi: 10.3389/fphys.2024.1473709. eCollection 2024.
7
Effect of Oral Administration of Collagen Peptide OG-5 on Advanced Atherosclerosis Development in ApoE Mice.口服胶原肽 OG-5 对载脂蛋白 E 小鼠动脉粥样硬化进展的影响。
Nutrients. 2024 Oct 31;16(21):3752. doi: 10.3390/nu16213752.
8
Antiatherosclerotic Effect and Molecular Mechanism of Salidroside.红景天苷的抗动脉粥样硬化作用及分子机制
Rev Cardiovasc Med. 2023 Mar 23;24(4):97. doi: 10.31083/j.rcm2404097. eCollection 2023 Apr.
9
Reversal of atherosclerosis by restoration of vascular copper homeostasis.通过恢复血管铜稳态逆转动脉粥样硬化。
Exp Biol Med (Maywood). 2024 Jun 24;249:10185. doi: 10.3389/ebm.2024.10185. eCollection 2024.
10
Advances in the treatment of atherosclerosis with ligand-modified nanocarriers.配体修饰纳米载体在动脉粥样硬化治疗中的进展。
Exploration (Beijing). 2023 Dec 7;4(3):20230090. doi: 10.1002/EXP.20230090. eCollection 2024 Jun.